These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 17906214)

  • 1. Role of forkhead box protein 3 expression in invasive breast cancer.
    Wolf AM; Rumpold H; Wolf D; Gastl G; Reimer D; Jenewein N; Marth C; Zeimet AG
    J Clin Oncol; 2007 Oct; 25(28):4499-500; author reply 4500-1. PubMed ID: 17906214
    [No Abstract]   [Full Text] [Related]  

  • 2. Small beginnings: do they matter? The importance of lymphovascular invasion in early breast cancer.
    Chivukula M; Brufsky A; Davidson NE
    J Natl Cancer Inst; 2009 May; 101(10):698-9. PubMed ID: 19436037
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistochemical expression and significance of epidermal growth factor receptor (EGFR) in breast cancer.
    Meche A; Cîmpean AM; Raica M
    Rom J Morphol Embryol; 2009; 50(2):217-21. PubMed ID: 19434314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
    Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
    Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXP3 expression and prognosis: role of both the tumor and T cells.
    Lu H
    J Clin Oncol; 2009 Apr; 27(11):1735-6. PubMed ID: 19255314
    [No Abstract]   [Full Text] [Related]  

  • 6. Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance.
    Habashy HO; Powe DG; Rakha EA; Ball G; Paish C; Gee J; Nicholson RI; Ellis IO
    Eur J Cancer; 2008 Jul; 44(11):1541-51. PubMed ID: 18538561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer.
    Al-Bazz YO; Underwood JC; Brown BL; Dobson PR
    Eur J Cancer; 2009 Mar; 45(4):694-704. PubMed ID: 19138840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness.
    Man YG; Schwartz A; Levine PH; Teal C; Berg PE
    Cancer Biomark; 2009; 5(1):9-17. PubMed ID: 19242057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic markers and long-term prognosis in breast cancer.
    Burtness BA
    Cancer J Sci Am; 1997; 3(4):211-2. PubMed ID: 9263626
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation of 70-gene prognosis signature in node-negative breast cancer.
    Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
    Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer.
    Nakamura R; Sakakibara M; Nagashima T; Sangai T; Arai M; Fujimori T; Takano S; Shida T; Nakatani Y; Miyazaki M
    Eur J Cancer; 2009 Aug; 45(12):2123-31. PubMed ID: 19398324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
    Sliwowska I; Kopczyński Z
    Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Occult multicentric breast cancer].
    Vtorushin SV; Zab'ialova MV; Glushchenko SA; Perel'muter VM; Slonimskaia EM
    Vopr Onkol; 2009; 55(1):38-41. PubMed ID: 19435197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D; Nielsen TO; Cheang MC; Foulkes WD
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
    Kim TH; Huh JH; Lee S; Kang H; Kim GI; An HJ
    Histopathology; 2008 Jul; 53(1):48-55. PubMed ID: 18479414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
    Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
    Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxA1 as a lineage-specific oncogene in luminal type breast cancer.
    Yamaguchi N; Ito E; Azuma S; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Tatsuta K; Inoue J; Semba K; Watanabe S
    Biochem Biophys Res Commun; 2008 Jan; 365(4):711-7. PubMed ID: 18039470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer.
    van Iterson V; Leidenius M; von Smitten K; Bono P; Heikkilä P
    Am J Clin Pathol; 2007 Nov; 128(5):759-66. PubMed ID: 17951197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
    Shah FD; Shukla SN; Shah PM; Shukla HK; Patel PS
    Indian J Cancer; 2009; 46(3):194-202. PubMed ID: 19574670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact.
    Casalini P; Carcangiu ML; Tammi R; Auvinen P; Kosma VM; Valagussa P; Greco M; Balsari A; Ménard S; Tagliabue E
    Clin Cancer Res; 2008 Jan; 14(1):25-31. PubMed ID: 18172248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.